Health ❯ Healthcare ❯ Biotechnology
Drug Development Cancer Treatment Autoimmune Diseases Obesity Treatments Immunotherapy Genetic Diseases Duchenne Muscular Dystrophy Antisense Oligonucleotides Cancer Therapy Muscular Dystrophy Pulmonary Sarcoidosis VIASKIN® Peanut Patch Cancer Research Nanobodies Alzheimer's Disease Dialysis Access Alcohol Use Disorder Drug Efficacy Dermatology Metabolic Diseases Diabetic Kidney Disease Frontotemporal Dementia Rare Diseases Pediatric Medicine Macrophage Therapy Vaccine Technology Regulatory Affairs Monoclonal Antibodies Phase 1 Studies AI in Medicine Inflammatory Bowel Disease Gene Therapy Eosinophilic Esophagitis Neurological Disorders Myasthenia Gravis Antibody Therapies
Want to see what podcasts are saying about this topic? Search across 120K+ podcasts. Explore Radar
The company says the proceeds will fund Symvess commercialization, with funds also used to prepare a BLA supplement seeking a hemodialysis indication.
